Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019

Details for Mechanism ID: 17460
Country/Region: Eswatini
Year: 2015
Main Partner: University Research Corporation, LLC
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: HHS/CDC
Total Funding: $4,061,946 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $294,322
Care: TB/HIV (HVTB) $75,882
Care: Pediatric Care and Support (PDCS) $183,773
Testing: HIV Testing and Counseling (HVCT) $225,919
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $59,487
Treatment: Adult Treatment (HTXS) $3,014,754
Treatment: Pediatric Treatment (PDTX) $207,809
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Age/sex: <1 Female 2016 35
CARE_CURR Age/sex: <1 Female 2016 958
CARE_CURR Age/sex: <1 Male 2016 9
CARE_CURR Age/sex: <1 Male 2016 448
CARE_CURR Age/sex: 1-4 Female 2016 35
CARE_CURR Age/sex: 1-4 Female 2016 1,296
CARE_CURR Age/sex: 1-4 Male 2016 35
CARE_CURR Age/sex: 1-4 Male 2016 1,316
CARE_CURR Age/sex: 10-14 Female 2016 37
CARE_CURR Age/sex: 10-14 Female 2016 1,830
CARE_CURR Age/sex: 10-14 Male 2016 37
CARE_CURR Age/sex: 10-14 Male 2016 1,811
CARE_CURR Age/sex: 15-19 Female 2016 36
CARE_CURR Age/sex: 15-19 Female 2016 1,929
CARE_CURR Age/sex: 15-19 Male 2016 35
CARE_CURR Age/sex: 15-19 Male 2016 1,899
CARE_CURR Age/sex: 20-24 Female 2016 32
CARE_CURR Age/sex: 20-24 Female 2016 3,499
CARE_CURR Age/sex: 20-24 Male 2016 42
CARE_CURR Age/sex: 20-24 Male 2016 3,285
CARE_CURR Age/sex: 25-49 Female 2016 64
CARE_CURR Age/sex: 25-49 Female 2016 3,604
CARE_CURR Age/sex: 25-49 Male 2016 106
CARE_CURR Age/sex: 25-49 Male 2016 3,943
CARE_CURR Age/sex: 5-9 Female 2016 37
CARE_CURR Age/sex: 5-9 Female 2016 1,571
CARE_CURR Age/sex: 5-9 Male 2016 38
CARE_CURR Age/sex: 5-9 Male 2016 1,586
CARE_CURR Age/sex: 50+ Female 2016 32
CARE_CURR Age/sex: 50+ Female 2016 1,583
CARE_CURR Age/sex: 50+ Male 2016 35
CARE_CURR Age/sex: 50+ Male 2016 1,663
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 645
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 32,279
CARE_CURR Sum of Age/Sex disaggregates 2016 645
CARE_CURR Sum of Age/Sex disaggregates 2016 32,221
CARE_NEW Age/sex: <1 Female 2016 117
CARE_NEW Age/sex: <1 Male 2016 99
CARE_NEW Age/sex: 1-4 Female 2016 213
CARE_NEW Age/sex: 1-4 Male 2016 218
CARE_NEW Age/sex: 10-14 Female 2016 339
CARE_NEW Age/sex: 10-14 Male 2016 320
CARE_NEW Age/sex: 15-19 Female 2016 412
CARE_NEW Age/sex: 15-19 Male 2016 390
CARE_NEW Age/sex: 20-24 Female 2016 602
CARE_NEW Age/sex: 20-24 Male 2016 557
CARE_NEW Age/sex: 25-49 Female 2016 607
CARE_NEW Age/sex: 25-49 Male 2016 676
CARE_NEW Age/sex: 5-9 Female 2016 294
CARE_NEW Age/sex: 5-9 Male 2016 294
CARE_NEW Age/sex: 50+ Female 2016 281
CARE_NEW Age/sex: 50+ Male 2016 301
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 5,722
CARE_NEW Sum of Age/sex disaggregates 2016 5,720
FPINT_SITE Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services 2016 3
FPINT_SITE Total number of PEPFAR-supported HIV service delivery points: PMTCT, Care and Treatment 2016 3
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 543
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 312
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 493
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 582
HTS_TST By Test Result: Negative 2016 1,111
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 1,930
HTS_TST Sum of Aggregated Age/Sex <15 2016 855
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 1,075
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 1,930
HTS_TST Sum of Test Result disaggregates 2016 1,207
HTS_TST_POS By Test Result: Positive 2016 96
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 82
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 2,061
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 75
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 1,856
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 41
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 959
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 34
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 889
PMTCT_ARV Sum of New and Current disaggregates 2016 75
PMTCT_ARV Sum of New and Current disaggregates 2016 1,848
PMTCT_EID By infants who received a virologic test within 2 months of birth 2016 1,832
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2016 142
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 1,985
PMTCT_EID Sum of Infant Age disaggregates 2016 1,974
PMTCT_STAT By: Known positives at entry 2016 30
PMTCT_STAT By: Known positives at entry 2016 573
PMTCT_STAT By: Number of new positives identified 2016 7
PMTCT_STAT By: Number of new positives identified 2016 1,585
PMTCT_STAT Number of new ANC and L&D clients 2016 59
PMTCT_STAT Number of new ANC and L&D clients 2016 5,990
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 57
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 5,689
PMTCT_STAT Sum of Positives Status disaggregates 2016 37
PMTCT_STAT Sum of Positives Status disaggregates 2016 2,158
TB_SCREEN Age: <1 2016 684
TB_SCREEN Age: 1-4 2016 2,397
TB_SCREEN Age: 10-14 2016 2,836
TB_SCREEN Age: 15-19 2016 4,144
TB_SCREEN Age: 5-9 2016 2,699
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 645
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 32,279
TB_SCREEN Sex: Female 2016 15,066
TB_SCREEN Sex: Male 2016 13,985
TB_SCREEN Sum of Age disaggregates 2016 29,051
TB_SCREEN Sum of Sex disaggregates 2016 29,051
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2016 29,051
TX_CURR Age/Sex: <1 Female 2016 8
TX_CURR Age/Sex: <1 Female 2016 377
TX_CURR Age/Sex: <1 Male 2016 8
TX_CURR Age/Sex: <1 Male 2016 373
TX_CURR Age/Sex: 1-4 Female 2016 29
TX_CURR Age/Sex: 1-4 Female 2016 1,376
TX_CURR Age/Sex: 1-4 Male 2016 30
TX_CURR Age/Sex: 1-4 Male 2016 1,375
TX_CURR Age/Sex: 5-14 Female 2016 64
TX_CURR Age/Sex: 5-14 Female 2016 2,756
TX_CURR Age/Sex: 5-14 Male 2016 65
TX_CURR Age/Sex: 5-14 Male 2016 2,764
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 562
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 28,068
TX_CURR Sum of age/sex disaggregates 2016 28,065
TX_CURR Sum of Age/Sex disaggregations 2016 562
TX_NEW By Age/Sex: <1 Female 2016 94
TX_NEW By Age/Sex: <1 Male 2016 93
TX_NEW By Age/Sex: 1-4 Female 2016 280
TX_NEW By Age/Sex: 1-4 Male 2016 282
TX_NEW By Age/Sex: 10-14 Female 2016 332
TX_NEW By Age/Sex: 10-14 Male 2016 323
TX_NEW By Age/Sex: 15-19 Female 2016 338
TX_NEW By Age/Sex: 15-19 Male 2016 320
TX_NEW By Age/Sex: 20-24 Female 2016 373
TX_NEW By Age/Sex: 20-24 Male 2016 367
TX_NEW By Age/Sex: 25-49 Female 2016 921
TX_NEW By Age/Sex: 25-49 Male 2016 816
TX_NEW By Age/Sex: 5-9 Female 2016 322
TX_NEW By Age/Sex: 5-9 Male 2016 315
TX_NEW By Age/Sex: 50+ Female 2016 275
TX_NEW By Age/Sex: 50+ Male 2016 254
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 5,704
TX_NEW Sum of Age/Sex disaggregates 2016 5,705
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2016 2,135
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2016 2,513
Cross Cutting Budget Categories and Known Amounts Total: $615,000
Human Resources for Health $100,000
Food and Nutrition: Policy, Tools, and Service Delivery $150,000
Gender: Gender Based Violence (GBV) $75,000
Post GBV Care
Collection and Use of Gender-related Strategic Information
Gender: Gender Equality $100,000
Increase gender-equitable access to income and productive resources, including education
Equity in HIV prevention, care, treatment and support
Capacity building
Motor Vehicles: Purchased $190,000